Overview: Urine Routine Examination Panel
Introduction: The Urine Routine Examination Panel is a diagnostic tool designed for general health screening using urine samples. In India, routine urinalysis detects early UTIs, diabetes (glycosuria), renal disease (proteinuria), and liver issues (bilirubin/urobilinogen), with high utility in antenatal, diabetes, and fever clinics. High morbidity from under-utilization in rural/low-SES populations, limited basic labs, delayed detection of UTI or kidney damage leading to complications. Per clinical pathology practices aligned with ICMR and Indian Society of Nephrology guidelines, the test employs spectrophotometry/microscopy for 16 parameters (color, appearance, pH, specific gravity, glucose, protein, ketones, bilirubin, urobilinogen, nitrite, leukocyte esterase, RBC, WBC, epithelial cells, casts, crystals) over 1â€"2 days with high accuracy, valuable for basic screening and monitoring. This diagnostic falls under urinalysis and targets routine health check-up, pregnant women, diabetics, or febrile patients, addressing accurate detection to guide antibiotics or further renal evaluation. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling affordable urine assessment and reducing preventable complications. Its urine-based approach ensures reliable macroscopic/microscopic evaluation.
Other Names: Urine RE Pnl.
FDA Status: FDA approved, CLIA certified for biochemistry/clinical pathology, compliant with 2025 standards.
Historical Milestone: Manual urine routine standard in primary care; in India, essential in RCH programs.
Purpose: The test assesses 16 parameters including color and glucose to guide general health screening, detect UTI/diabetes/renal issues, inform therapy.
Test Parameters: 1. Color, 2. Appearance, 3. pH, 4. Specific Gravity, 5. Glucose, 6. Protein, 7. Ketones, 8. Bilirubin, 9. Urobilinogen, 10. Nitrite, 11. Leukocyte Esterase, 12. RBC, 13. WBC, 14. Epithelial Cells, 15. Casts, 16. Crystals.
Pretest Condition: No fasting required; patients should provide midstream urine.
Specimen: 10 mL urine in sterile container, transported within specified times to maintain sample viability.
Sample Stability at Room Temperature: 2 hours with proper handling to preserve cellular elements, ensuring reliable test performance.
Sample Stability at Refrigeration: 24 hours at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.
Sample Stability at Frozen: Not frozen (fresh sample preferred for microscopy).
Medical History: Patients should provide details on symptoms, pregnancy, diabetes.
Consent: Written informed consent is required, detailing the test's purpose, potential risks of undetected abnormality including UTI/renal disease, benefits of screening, and minimal discomfort from urine collection.
Procedural Considerations: The test involves sample processing using spectrophotometry/microscopy by trained personnel to ensure sterile technique and interpret results within 1â€"2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.
Factors Affecting Result Accuracy: Delays beyond stability periods, improper storage conditions, or contamination can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.
Clinical Significance: Positive nitrite/leukocyte esterase indicates UTI; glycosuria/proteinuria suggests diabetes/renal issue, necessitating specialist input.
Specialist Consultation: General physicians or nephrologists should be consulted for management.
Additional Supporting Tests: Urine culture, renal function tests for confirmation.
Test Limitations: Manual method may miss subtle changes; comprehensive approach required.
References: Indian Journal of Medical Microbiology 2024, Urinalysis Studies India 2023.
